Friday, 3 March 2017
Drugs firm lower the costs of 14 key cancer drugs
Drugs firm lower the costs of 14 key cancer drugs Drugs giants including Bayer, Novartis and Pfizer have lowered the costs of 14 key cancer medicines after the NHS threatened to stop paying for them following a review of costs. The Daily Mail
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment